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Abstract
The chromosomal passenger complex (CPC-INCENP, Aurora B kinase, Survivin and Borealin) is
implicated in many mitotic processes. Here we describe how we generated DT40 conditional
knockout cell lines for incenp1 and survivin1 to better understand the role of these CPC subunits
in the control of Aurora B kinase activity. These lines enabled us to reassess current knowledge of
Survivin function and to show that INCENP acts as a rheostat for Aurora B activity.
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INTRODUCTION
Accurate chromosome segregation requires that kinetochores of sister chromatids bind
microtubules that emanate from opposing spindle poles. During prometaphase, various
aberrant kinetochore attachments occur which, if not corrected, can lead to improper
chromosome segregation and aneuploidy. To avoid this, cells have a surveillance
mechanism, called the spindle checkpoint, which delays anaphase until all sister
kinetochores are properly captured and under tension. Kinetochore attachment and error
correction are directly controlled by the Aurora B kinase, part of the chromosomal passenger
complex (CPC).
In most organisms, the core CPC is composed of Aurora B kinase [1] and three non-
enzymatic subunits, INCENP [2, 3], Survivin and Borealin/Dasra B [4-7] that control
targeting, enzymatic activity and stability of Aurora B kinase [8]. The CPC controls many
aspects of mitosis ranging from chromosome and spindle structure to the correction of
kinetochore-microtubule attachment errors, regulation of mitotic progression and completion
of cytokinesis [9]. Knockdown by RNA interference of any member of the complex disrupts
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mitotic progression [4, 7, 10-13]. Although INCENP has been shown to be responsible for
the initial Aurora B activation through direct binding and a phosphorylation feedback loop
[9, 14, 15], the mechanisms responsible for controlling the activity of this important kinase
are still poorly understood.
The ability to shut down/off the expression of a gene by RNAi or knockout is widely used to
study protein function in many eukaryotic systems. Whereas RNAi relies upon the
destruction of the mRNA, which is continuously produced, conditional knockouts block
production of the mRNA at its source. Another advantage of knockout strategies over RNAi
is the absence of off-target effects [16]. Several cell types are used to generate knockouts
including mouse ES cells, human RPE, Nalm-6, HT1080 and chicken DT40 cell lines
[17-22].
DT40 cells are chicken B lymphoma with a very high rate of homologous recombination (up
to 90% for some loci), greatly facilitating gene targeting. DT40s have been used to study
many biological processes, including DNA damage pathways [23], transcriptional regulation
[24], calcium signalling [25], apoptosis [26-29] and chromatin structure [30-32].
To better understand the role of the CPC in regulating Aurora B activity we studied the
involvement of INCENP and Survivin by generating DT40 conditional knockout cell lines
for their genes [33, 34].
1- Assessment of SURVIVIN function in mitosis and apoptosis
Survivin is a protein involved in mitotic progression and apoptotic regulation that is up-
regulated in many human tumours. Survivin’s expression peaks during mitosis [8, 35, 36].
The protein is required for targeting the CPC to centromeres [8, 37]. Survivin is considered a
member of the inhibitor of apoptosis protein (IAP) family, despite lacking some of the key
features shared by other members of the family. The exact role of Survivin in mitosis and
apoptosis remains unclear.
Our lab generated two DT40 conditional knockouts of the survivin gene. We used this
system to study the role of Survivin both in mitosis and apoptosis and to assess the role of
key residues of the proteins in these biological processes.
1-1 KNOCKOUT STRATEGY
Survivin−/− cells were generated by deleting the entire survivin1 gene (Acc. N°:
ENSGALG00000008713, Figure 1A). Briefly, after targeting and replacement of the first
allele by a resistance marker, the survivin cDNA, regulated by a Tet off system, was
introduced in the heterozygous cells. The second allele was then targeted, generating a
conditional Survivin knockout cell line which, upon addition of doxycycline exhibits the
null phenotype. Stable transfection of this cell line with various Survivin cDNA-bearing
mutations of interest allowed us to study their phenotypes in a null background.
1-2 THE ROLE of SURVIVIN in MITOSIS
Using our unique survivin−/− model, we confirmed some previous findings on Survivin
function and revealed important features of key residues of the protein. For instance, we
showed that Survivin is essential for both chromosome segregation and cytokinesis,
concordant with observations from RNAi studies [12, 13]. A mutant previously shown to
abolish interaction between Survivin and Aurora B (human SurvivinD70A/D71A, chicken
SurvivinD72A/D73A) [38] introduced into the Survivin knockout cells was unable to
concentrate normally at centromeres. This induced delocalization of the other passenger
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proteins in early mitosis, surprisingly without affecting subsequent transfer of the CPC to
the spindle midzone. Furthermore, this mutant showed a compromised spindle checkpoint.
Unexpectedly, despite the presence of these defects, this mutant could progress through
mitosis and sustain cell growth, suggesting that Survivin binding to Aurora B is not
absolutely required for cell survival [34]. In contrast with RNAi studies, we didn’t observe
any significant increase in defects in early phases of mitosis such as chromosome
misalignment or abnormal spindles in the absence of survivin [12, 13, 39-41]. Survivin−/−
cells exhibited mitotic arrest at high doses of taxol whereas at lower doses they could
override the spindle checkpoint and progress through mitosis. This override was
concomitant with increased apoptosis suggesting abnormal mitotic exit and subsequent cell
death occurring in interphase [34].
1-3 THE ROLE of SURVIVIN in CELL DEATH
Similarly to what we observed for mitosis, survivin−/− cells enabled us to confirm some
previously described results regarding Survivin’s role in apoptosis and to contradict others.
For instance we could confirm that some mutations in specific domains of Survivin did
induce a loss of function phenotype, such as point mutations in the BIR domain
(SurvivinC59A or SurvivinC86A) [42]. On the other hand, loss of Survivin did not induce an
increased sensitivity to pro-apoptotic stimuli. Furthermore, abolition of Survivin binding to
Smac (SurvivinD55A), an antagonist of Survivin involved in apoptosis, did not prevent cell
growth nor did it display a pro-apoptotic phenotype, contradicting previous reports about the
protective role of Survivin in apoptosis [42-46].
1-4 CONCLUSIONS
Generation of DT40 survivin−/− cells expressing various mutants, allowed us to reassess
Survivin functions both in mitosis and in apoptosis in complete absence of the endogenous
wild-type protein. The null background proved to be essential to study Survivin function.
Discrepancies observed between our study and previous reports demonstrate the importance
of a genetically-clean system to dissect the protein functions. Our study ultimately proved
that cell death induced by loss of Survivin is linked to cell cycle defects (primarily a failure
in cytokinesis) rather than disregulation of apoptosis.
2- Functionnal analysis of INCENP-Aurora B interactions
INCENP is the scaffolding protein of the CPC [2, 3]. Its N-terminus is required for
centromere targeting of the complex whereas its C-terminus contains the IN box where
Aurora B binds and gets activated. To study in more detail the interactions between
INCENP and Aurora B, we generated a conditional DT40 knockout for incenp1 (Acc. N°:
ENSGALG00000007537), expressing INCENP bearing specific point mutations in the IN
box. We chose residues predicted to be important for activation (W766) or binding of
Aurora B (F802) to INCENP [15].
2-1 KNOCKOUT STRATEGY
To generate an incenp1 knockout, we used a promoter hi-jack strategy (Figure 1B) [33, 47].
Here, the first allele was placed under the control of a Tet off system, which was achieved
by replacing the endogenous promoter with a minimal CMV/TetO promoter, together with
stable expression of the tTA/VP16 transactivator under the control of the kif4A promoter.
The other incenp1 allele had its ORF disrupted, potentially allowing expression of only the
28 first amino acids of the protein. In these cells, the addition of doxycycline shuts off
expression from the endogenous incenp1 allele (Figure 2A, B). This strategy enabled the
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conditional expression of the multiple spliced isoforms of INCENP (class I and class II)
[48].
2-2 Regulation of Aurora B activity through INCENP binding
We used this system to study how interactions between INCENP and Aurora B affect the
activity of the kinase along with CPC function and localisation. The two mutants generated
had different binding capacity to Aurora B leading to different levels of kinase activity.
Expression of INCENPW766G in absence of wild-type INCENP abolished Aurora B
interaction with INCENP, reducing Aurora B activity by 70%. INCENPF802A mutant bound
Aurora B in a normal fashion but kinase activity was reduced by 50% contrasting with
predictions from previous structural analysis [15]. Expression of either INCENPW766G or
INCENPF802A in a null background induced cytokinesis failure and rapid cell death [33].
Both INCENPW766G and INCENPF802A were properly localised at centromeres in early
mitosis but failed to transfer to the spindle midzone in anaphase. We could thus demonstrate
that mitotic entry and sister chromatid separation are independent of CPC formation or
Aurora B activity whereas both are required for proper transfer of the CPC to the spindle
midzone and completion of cytokinesis [33]. Despite reports from RNAi experiments
showing that Aurora B activity is required for outer kinetochore assembly [49, 50], we were
able to detect CENP-A, -H, -O, -T, -E and the Hec1/Ndc80 complex at kinetochores of
prometaphase incenp1−/− cells suggesting that kinetochore assembly is not affected by the
lack of CPC at centromeres [33]. Moreover, CENP-E and PRC-1 localisation to the spindle
midzone of incenp1−/− anaphase cells demonstrated that a spindle midzone was present
despite the absence of CPC [33].
Expressing INCENP mutants in a null background enabled us to analyse the relationship
between Aurora B kinase activity and the spindle checkpoint response induced by taxol. We
established that various Aurora B activity levels yielded different spindle checkpoint
responses when cells were treated with low doses of taxol. A minimal Aurora B activity
(~50%, INCENPF802A) was sufficient to trigger a checkpoint response whereas lower
activity (~30%, INCENPW766G or 15% with Aurora B inhibitor) only induced a weak
checkpoint response [33]. This probably reflects the ability of the kinase to correct
kinetochore-microtubules mis-attachments.
2-3 CONCLUSION
We mutated residues of INCENP that were predicted by crystallography studies to affect
Aurora B binding or activity. Using incenp1−/− cells, we could assess the in vivo effects of
mutating these residues. We were able to show that modulation of Aurora B activity
regulates CPC localisation and function during mitosis. Ultimately, the use of DT40
incenp1−/− cells expressing various mutants allowed us to strengthen the model in which
INCENP acts as a rheostat for Aurora B activity [33].
3- CONCLUSIONS
The DT40 cell line is a powerful system to study protein function. The ability to perform
conditional knockouts of essential, multiply-spliced cell cycle-regulated genes makes it an
ideal system to screen for and characterise functional domains or residues through the
analysis of specific mutants against a null background.
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ABBREVIATIONS
CPC Chromosomal Passenger Complex
IAP Inhibitor of Apoptosis Protein
ORF Open Reading Frame
TetO tet operator
tTA Transactivator
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Figure 1. Schematic representation of the DT40 gene disruption and “conditional promoter”
A, Gene disruption strategy: The first survivin1 allele is fully replaced with a resistance
marker by homologous recombination (1). In a second step, a rescue construct containing,
the transactivator (tTA/VP16) under control of either kif4a or CMV promoter and the
Survivin cDNA under control of tet operator (TetO) are randomly integrated (2). Finally, the
second survivin1 allele is targeted and replaced by a resistance marker (3). Addition of
doxycycline (dox) turns off the expression of the exogenous cDNA giving the null
phenotype. cDNA encoding Survivin mutants are randomly integrated (4). Addition of
doxycycline allows the observation of the mutant phenotype in a null background. B,
Conditionnal promoter strategy: In a first step, the promoter of the first incenp1 allele is
swapped with a TetO by homologous recombination (1). The second step involves random
integration of a construct containing the tTA under control of the kif4a promoter (2). In a
third step, the second incenp1 allele is disrupted by a resistance marker (3). The addition of
doxycycline turns off the expression of the allele regulated by the TetO promoter giving the
null phenotype. Random integration of wild type or mutant INCENP cDNAs (4) enables,
after addition of doxycycline, the observation of their phenotype in a null background.
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Figure 2. The conditional INCENP knockout model
A, Immunofluorescence of DT40 (INCENP+/+), DT40 INCENP−/− or DT40 INCENP−/−
expressing INCENP class I after 24h of doxycycline stained for INCENP (green) and DNA
(blue). Bar 10 μm. B, Immunoblot comparing the levels of INCENP protein in INCENP+/+
cells, INCENP−/− and in the INCENP−/− cells transfected with INCENP classI cDNA 24h
after addition of doxycycline. Note the presence of two isoforms, class I and II in the wild
type cells and the total absence of the protein in the knockout cells.
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